Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 62 Next >>

Filter Applied: drug induced neurologic disorders (Click to remove)

Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000

Adverse Drug Effects Attributed to Phenylpropanolamine:A Review of 142 Case Reports
Am J Med 89:195-208, Lake,C.R.,et al, 1990

Acute Cocaine Poisoning
Am J Med 75:1061-1064, Jonsson,S.,et al, 1983

Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023

Involuntary Groaning Induced by Levodopa Therapy in a Patient With Progressive Supranuclear Palsy
JAMA Neurol 77:1569, Park, J.E., 2020

A Case of Altered Mental Status, Not Otherwise Specified
Neurol 89:e154-e158, Swor, D.E.,et al, 2017

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

An Algorithm (Decision Tree) for the Management of Parkinson's Disease:Trtm Guidelines
Neurol 50:S1-S57, Olanow,C.W.&Koller,W.C., 1998

Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients
Neurol 51:811-814, Goetz,C.G.,et al, 1998

Clinicopath Conf
Qunidine-Induced Thrombocytopenia, Cerebral Hemorrhage, Case 15-1995, NEJM 332:1363-137095., , 1995

Neurotoxicity in Liver Transplant Recipients with Cyclosporine Immunosuppression
Neurol 45:1962-1964, Wijdicks,E.F.M.,et al, 1995

Evaluation and Management of the Patient with Syncope
JAMA 268:2553-2560, Kapoor,W.N., 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

Diagnostic Evaluation of Syncope
Am J Med 90:91-106, Kapoor,W., 1991

Cyclosporine-Related Central Nervous System Toxicity in Cardiac Transplantation
NEJM 323:420-421, Hughes,R.L., 1990

Drug-Induced Movement Disorders
Postgrad Med 180, 1971, Sept., North,R., 1971

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Dupuytren, Ledderhose, and Peyronie Diseases after Primidone Use for Essential Tremor
Neurologist 24:150-151, Felipe, L.,et al, 2019

Antibiotic-Associated Encephalopathy
Neurol 86:963-971, Bhattacharyya, S.,et al, 2016

Delayed Onset of Progressive Chorea After Acute Basal Ganglia Injury
Mov Disord 28:585-587, Virmani, T.,et al, 2013

Varicella-Zoster Virus Encephalitis and Vasculopathy in a Patient Treated with Fingolimod
Neurol 79:2002-2004,1942, Ratchford, J.,et al, 2012

Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011

Lamotrigine: An Unusual Etiology for Aseptic Meningitis
Neurologist 16:35-36, Lam,G.,et al, 2010

The Clinical and Radiological Spectrum of Reversible Cerebral Vasoconstriction Syndrome. A Prospective Series of 67 Patients
Brain 130:3091-3101, Ducros, A.,et al, 2007

The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005

Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004

Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003

Dysgeusia in Epileptic Patients Treated with Lamotrigine: Report of Three Cases
Neurol 57:1521, Avoni,P.,et al, 2001

Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001

Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000

Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Arch Int Med 159:281-284, Ben-Ami,H.,et al, 1999

Gabapentin-Induced Anorgasmia
Neurol 53:2209, Clark,J.D.&Elliott,J., 1999

Hypoxic/Ischaemic Brain Damages, Especially Pallidal Lesions, in Heroin Addicts
Forensic Sci Int 102:51-59, Andersen,S.N. &Skullerud,K., 1999

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Opsoclonus
Semin Neurol 16:21-26, Averbuch-Heller,L.&Remler,B., 1996

Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996

Serotonin Syndrome
Neurol 45:219-223, Bodner,R.A.,et al, 1995

Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy
Ann Neurol 38:687-691, Papazian,O.,et al, 1995

Neurologic Manifestations of Cocaine Exposure in Childhood
Pediatrics 93:557-560, Mott,S.H.,et al, 1994

Seizure Exacerbation and Status Epilepticus Related to Carbamazepine-10, 11-Epoxide
Ann Neurol 35:743-746, So,E.L.,et al, 1994

Choreiform Movements Associated with the Use of Valproate
Arch Neurol 51:702-704, Lancman,M.E.,et al, 1994

Status Epilepticus at an Urban Public Hospital in the 1980s
Neurol 43:483-488, Lowenstein,D.H.&Alldredge,B.K., 1993

Drug Induced Creutzfeldt-Jakob Like Syndrome
J Psychiatr Neurosci 17:103-105, Finelli,P.F., 1992

Cerebrovascular Events After Myocardial Infarction:Analysis of the GISSI Trial
BMJ 302:1428-1431, Maggioni,A.P.,et al, 1991

Thiamine Deficiency in Patients with Congestive Heart Failure Receiving Long-Term Furosemide Therapy:A Pilot Study
Am J Med 91:151-155, Seligmann,H.,et al, 1991

Nontraumatic Coma, Glasgow Coma Score and Coma Etiology as Predictors of 2-Week Outcome
Arch Neurol 47:1181-11884, Sacco,R.L.,et al, 1990

Myoclonus Associated with Treatment with High Doses of Morphine:The Role of Supplemental Drugs
BMJ 299:150-153, Potter,J.M.,et al, 1989

Carbamazepine Update
Editorial, Lancet 2:595-5971989., , 1989

Seizures Associated with Recreational Drug Abuse
Neurol 39:1037-1039, Alldredge,B.K.,et al, 1989



Showing articles 0 to 50 of 62 Next >>